Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Messenger RNA (mRNA) vaccines represent a new, effective vaccine platform with high capacity for rapid development. Generation of a universal influenza virus vaccine with the potential to elicit long-lasting, broadly cross-reactive immune responses is a necessity for reducing influenza-associated mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardi, Norbert, Carreño, Juan Manuel, O’Dell, George, Tan, Jessica, Bajusz, Csaba, Muramatsu, Hiromi, Rijnink, Willemijn, Strohmeier, Shirin, Loganathan, Madhumathi, Bielak, Dominika, Sung, Molly M. H., Tam, Ying K., Krammer, Florian, McMahon, Meagan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362976/
https://www.ncbi.nlm.nih.gov/pubmed/35945226
http://dx.doi.org/10.1038/s41467-022-32149-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362976/
https://www.ncbi.nlm.nih.gov/pubmed/35945226
http://dx.doi.org/10.1038/s41467-022-32149-8

Ejemplares similares